The Medical Letter on Drugs and Therapeutics
FROM
ISSUE
1656
August 8, 2022
View Complete Issue         Table of Contents 2019 
Issue 1656
Subscribers: Log in to read full issue.  Not a subscriber?  Subscribe or purchase issue.
COVID-19 Update: FDA Authorizes Novavax COVID-19 Vaccine
August 8, 2022 (Issue: 1656)
The FDA has issued an Emergency Use Authorization (EUA) for an adjuvanted protein subunit COVID-19 vaccine manufactured by Novavax. The vaccine is indicated for use as a two-dose primary series to prevent COVID-19 in adults; it is not...more
The Medical Letter is a subscriber-funded nonprofit organization that publishes critical appraisals of new prescription drugs and comparative reviews of drugs for common diseases.

Would you like to read the rest of this issue?  Gain access below.

Subscribe
Subscriptions to The Medical Letter on Drugs and Therapeutics include:
  • Print version published and mailed biweekly (26 issues/year)
  • Unlimited online access to current and past issues (1988 - present)
  • Mobile App
  • FREE online per issue CME/CE
Purchase this issue:
Title: Issue 1656
 


Gain access through your organization
Ask your librarian to consider an Institutional Subscription to The Medical Letter.